Polynovo Ltd (ASX: PNV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.68 billion
P/E Ratio 352.00
Dividend Yield 0.00%
Shares Outstanding 690.69 million
Earnings per share 0.008
Dividend per share N/A
Year To Date Return 41.99%
Earnings Yield 0.28%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Polynovo Ltd (ASX: PNV)
    Latest News

    A woman's hand draws a stylised 'Top Ten' on a projected surface.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a wistful Wednesday for ASX investors today.

    Read more »

    piggy bank at end of winding road
    Share Gainers

    Here are the top 10 ASX 200 shares today

    ASX investors enjoyed a lucrative Tuesday session today.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    Today's trading gave ASX investors some much-needed relief.

    Read more »

    A young man sits on the floor with his back against a sofa hunched over his phone in one hand and his other hand on top of his head as though he is seeing bad news as his face looks sad and anguished.
    Share Market News

    Here are the top 10 ASX 200 shares today

    ASX investors copped yet another bruising in the markets today.

    Read more »

    A young girls clings in fright to a big red slide.
    Share Market News

    Here are the top 10 ASX 200 shares today

    Investors were hitting the sell button hard today...

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Clearview, Loyal Lithium, Polynovo, and Weebit Nano shares are falling

    These shares are ending the week deep in the red. But why?

    Read more »

    Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX 200 has hit three out of three days of gains this week.

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Share Gainers

    Why Flight Centre, Nine Entertainment, Polynovo, and QANTM shares are pushing higher

    These shares are having a good time on hump day. But why?

    Read more »

    Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
    Healthcare Shares

    This ASX 200 healthcare stock is rocketing 8% following a record month!

    Investors are impressed with this update. Here's why.

    Read more »

    Man smiling at a laptop because of a rising share price.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX ended the trading week on a high today.

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    Let's also take a look at what the various ASX sectors were doing this Wednesday.

    Read more »

    Businessman smiles with arms outstretched after receiving good news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was another strong showing from the share market today.

    Read more »

    Frequently Asked Questions

    The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX  on 26 November 1998 and is headquartered in Melbourne.

    No, the company does not historically pay dividends.

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    04 Oct 2024 $2.43 $-0.09 -3.57% 940,023 $2.49 $2.50 $2.43
    03 Oct 2024 $2.52 $-0.07 -2.70% 1,379,379 $2.59 $2.61 $2.47
    02 Oct 2024 $2.59 $-0.06 -2.26% 1,939,507 $2.60 $2.68 $2.58
    01 Oct 2024 $2.65 $0.04 1.53% 1,274,061 $2.60 $2.65 $2.58
    30 Sep 2024 $2.61 $-0.03 -1.14% 949,389 $2.63 $2.64 $2.57
    27 Sep 2024 $2.64 $-0.01 -0.38% 881,372 $2.62 $2.64 $2.58
    26 Sep 2024 $2.65 $0.09 3.52% 2,413,526 $2.57 $2.67 $2.56
    25 Sep 2024 $2.56 $0.01 0.39% 1,355,809 $2.55 $2.57 $2.52
    24 Sep 2024 $2.55 $0.06 2.41% 2,210,607 $2.48 $2.55 $2.48
    23 Sep 2024 $2.49 $0.03 1.22% 1,081,133 $2.39 $2.50 $2.39
    20 Sep 2024 $2.46 $0.00 0.00% 3,361,292 $2.49 $2.50 $2.42
    19 Sep 2024 $2.46 $-0.10 -3.91% 2,047,170 $2.56 $2.56 $2.46
    18 Sep 2024 $2.56 $-0.05 -1.92% 1,772,649 $2.59 $2.65 $2.55
    17 Sep 2024 $2.61 $0.16 6.53% 1,879,768 $2.50 $2.61 $2.48
    16 Sep 2024 $2.45 $-0.13 -5.04% 1,204,337 $2.59 $2.60 $2.45
    13 Sep 2024 $2.58 $0.04 1.57% 1,517,793 $2.56 $2.59 $2.53
    12 Sep 2024 $2.54 $0.12 4.96% 1,931,492 $2.50 $2.54 $2.43
    11 Sep 2024 $2.42 $-0.05 -2.02% 1,392,794 $2.48 $2.52 $2.40
    10 Sep 2024 $2.47 $0.12 5.11% 2,507,632 $2.38 $2.52 $2.38
    09 Sep 2024 $2.35 $0.02 0.86% 1,328,233 $2.27 $2.37 $2.27
    06 Sep 2024 $2.33 $0.03 1.30% 1,276,843 $2.29 $2.34 $2.27

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Sep 2024 Andrew Lumsden Sell 50,000 $130,915
    On-market trade.
    26 Sep 2024 Leon Hoare Sell 100,000 $260,839
    On-market trade. As per announcement on 02-01-2024
    13 Sep 2024 Bruce Rathie Sell 750,000 $1,886,900
    On-market trade.
    31 Oct 2023 Robyn Elliott Buy 32,000 $38,080
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams is a director and investment banker with a track record in business development, mergers and acquisitions, and capital raising. He has experience advising companies in the food, medical device, and pharmaceutical sectors. Mr Williams is currently Managing Director of corporate advisory firm Kidder Williams.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott has a track record in product development, clinical trials, regulatory affairs, audits, quality management, project management and operational strategy. Her worldwide experience in new facility delivery, production scale up, strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally. Dr Elliott was Global Head, Strategic Portfolio Management at CSL Behring, a role that is responsible for governance oversight and business value delivery. Dr Elliott is a member of the Risk Committee.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden has more than 20 years of experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer. Prior to joining Wellcom, Mr Lumsden was a Senior Manager within the Audit and Assurance practice of PricewaterhouseCoopers. Mr Lumsden is the Chair of the Risk Committee.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare has expertise across multiple Life Sciences sectors. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew (S&N) ANZ. He served as President of S&N's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly is an IP and business development professional with more than 30 years of local and international experience. She has been on the Board of the Institute of Patent and Trademark Attorneys of Australia for over a decade. Ms Emmanuel-Donnelly was Executive Manager of Business Development and Commercial at the CSIRO, was in-house IP Counsel for Unilever in the U.K., and practiced as a patent and trademark attorney for Wilson Gunn.
    Mr Lior Harel Company SecretaryGeneral Counsel May 2024
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan Gielen Chief Financial Officer
    -
    Philip Scorgie Chief Information Officer
    -
    Joseph Amaral Chief Medical Officer (part-time)
    -
    Ingrid Anderson Chief People Officer
    -
    David McQuillan Chief Technical and Scientific Officer
    -
    Lior Harel Company SecretaryGeneral Counsel
    -
    David Morris President Asia Pacific
    -
    Edward Graubart President North America
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 96,149,727 13.93%
    J P Morgan Nominees Australia Pty Limited 80,078,534 11.60%
    Citicorp Nominees Pty Limited 37,720,578 5.46%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    Lateral Innovations Pty Ltd (Trust A/C 10,924,103 1.58%
    Mr Anthony Shane Kittel Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,050,000 1.17%
    Bnp Paribas Noms Pty Ltd 7,622,413 1.10%
    National Nominees Limited 6,653,041 0.96%
    Netwealth Investments Limited (Wrap Services A/C) 5,394,880 0.74%
    BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient) 4,533,452 0.66%
    BNP Paribas Nominees Pty Ltd (Agency Lending A/C) 4,414,903 0.64%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mrs Li-Hsien Tsai 3,955,424 0.57%
    Mr David Kenley 3,755,000 0.54%
    Mr Paul Gerard Brennan 3,569,796 0.52%
    Mr Matthew James Avery 3,439,332 0.50%
    Mr David Kenley i 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Evan Philip Clucas Ms Leanne Jane Weston (Kuranga Nursery Super A/C) 2,931,149 0.42%
    Mr Chris Dawborn (Haskali Super Fund A/C) 2,870,271 0.42%

    Profile

    since

    Note